These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8094975)

  • 1. Selective modulation of vinblastine sensitivity by 1,9-dideoxyforskolin and related diterpenes in multidrug resistant tumour cells.
    Shalinsky DR; Heath DD; Jekunen AP; Alcaraz JE; Howell SB
    Br J Cancer; 1993 Mar; 67(3):471-9. PubMed ID: 8094975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of vinblastine sensitivity by dipyridamole in multidrug resistant fibrosarcoma cells lacking mdr1 expression.
    Shalinsky DR; Slovak ML; Howell SB
    Br J Cancer; 1991 Oct; 64(4):705-9. PubMed ID: 1680368
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of initial vinblastine influx by P-glycoprotein.
    Shalinsky DR; Jekunen AP; Alcaraz JE; Christen RD; Kim S; Khatibi S; Howell SB
    Br J Cancer; 1993 Jan; 67(1):30-6. PubMed ID: 8094005
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Modulation of drug sensitivity by dipyridamole in multidrug resistant tumor cells in vitro.
    Shalinsky DR; Andreeff M; Howell SB
    Cancer Res; 1990 Dec; 50(23):7537-43. PubMed ID: 1979245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partial reversal of doxorubicin resistance by forskolin and 1,9-dideoxyforskolin in murine sarcoma S180 variants.
    Wadler S; Wiernik PH
    Cancer Res; 1988 Feb; 48(3):539-43. PubMed ID: 2825978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interaction of forskolin with the P-glycoprotein multidrug transporter.
    Morris DI; Speicher LA; Ruoho AE; Tew KD; Seamon KB
    Biochemistry; 1991 Aug; 30(34):8371-9. PubMed ID: 1679346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered pharmacokinetics of vinblastine in Mdr1a P-glycoprotein-deficient Mice.
    van Asperen J; Schinkel AH; Beijnen JH; Nooijen WJ; Borst P; van Tellingen O
    J Natl Cancer Inst; 1996 Jul; 88(14):994-9. PubMed ID: 8667431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Agents which reverse multidrug-resistance are inhibitors of [3H]vinblastine transport by isolated vesicles.
    Horio M; Lovelace E; Pastan I; Gottesman MM
    Biochim Biophys Acta; 1991 Jan; 1061(1):106-10. PubMed ID: 1671642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential effects of toremifene on doxorubicin, vinblastine and Tc-99m-sestamibi in P-glycoprotein-expressing breast and head and neck cancer cell lines.
    Mubashar M; Harrington KJ; Chaudhary KS; Lalani el-N; Stamp GW; Peters AM
    Acta Oncol; 2004; 43(5):443-52. PubMed ID: 15360048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of doxorubicin, etoposide, vinblastine, and taxol resistance in multidrug resistant human sarcoma cells by a polymer of spermine.
    Gosland MP; Gillespie MN; Tsuboi CP; Tofiq S; Olson JW; Crooks PA; Aziz SM
    Cancer Chemother Pharmacol; 1996; 37(6):593-600. PubMed ID: 8612315
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of organic isothiocyanates on the P-glycoprotein- and MRP1-mediated transport of daunomycin and vinblastine.
    Tseng E; Kamath A; Morris ME
    Pharm Res; 2002 Oct; 19(10):1509-15. PubMed ID: 12425469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
    Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reversal of doxorubicin resistance by hydrophobic, but not hydrophilic, forskolins.
    Wadler S; Yang CP
    Mol Pharmacol; 1991 Dec; 40(6):960-4. PubMed ID: 1684637
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of drug transport kinetics in multidrug-resistant cells using a novel coumarin-vinblastine compound.
    Bornmann WG; Roepe PD
    Biochemistry; 1994 Oct; 33(42):12665-75. PubMed ID: 7918493
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of P-glycoprotein transport function and reversion of MDR1 multidrug resistance by cnidiadin.
    Barthomeuf C; Grassi J; Demeule M; Fournier C; Boivin D; Béliveau R
    Cancer Chemother Pharmacol; 2005 Aug; 56(2):173-81. PubMed ID: 15824923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transepithelial vinblastine secretion mediated by P-glycoprotein is inhibited by forskolin derivatives.
    Hunter J; Hirst BH; Simmons NL
    Biochem Biophys Res Commun; 1991 Dec; 181(2):671-6. PubMed ID: 1684494
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potent reversal of multidrug resistance by ningalins and its use in drug combinations against human colon carcinoma xenograft in nude mice.
    Chou TC; Guan Y; Soenen DR; Danishefsky SJ; Boger DL
    Cancer Chemother Pharmacol; 2005 Oct; 56(4):379-90. PubMed ID: 15875185
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
    Kataoka Y; Ishikawa M; Miura M; Takeshita M; Fujita R; Furusawa S; Takayanagi M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 2001 Jun; 24(6):612-7. PubMed ID: 11411546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Liposome-mediated modulation of multidrug resistance in human HL-60 leukemia cells.
    Rahman A; Husain SR; Siddiqui J; Verma M; Agresti M; Center M; Safa AR; Glazer RI
    J Natl Cancer Inst; 1992 Dec; 84(24):1909-15. PubMed ID: 1361008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Partial purification and reconstitution of the human multidrug-resistance pump: characterization of the drug-stimulatable ATP hydrolysis.
    Ambudkar SV; Lelong IH; Zhang J; Cardarelli CO; Gottesman MM; Pastan I
    Proc Natl Acad Sci U S A; 1992 Sep; 89(18):8472-6. PubMed ID: 1356264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.